Gilead Sciences Reports Almost $900 Mn In Q3 Remdesivir Sales
Muhammad Irfan Published October 29, 2020 | 08:40 AM
New York, (UrduPoint / Pakistan Point News - 29th Oct, 2020 ) :Remdesivir, a therapeutic to treat Covid-19, boosted third-quarter sales for pharma company Gilead Sciences by nearly $900 million, according to results released Wednesday by the drugmaker.
The medication, sold under the brand name Veklury, which was originally developed to treat Ebola, has been shown to shorten the recovery time for patients hospitalized with the coronavirus. Gilead reported a 17 percent jump in third-quarter revenues to $6.6 billion.
Recent Stories
At least 10 people killed in Brazil fire: officials
1 hour ago
Shahzaib Rind calls on Deputy Speaker Balochistan
1 hour ago
Ahsan chairs 13th CPEC-JCC preparatory meeting, reviews arrangements for high-le ..
1 hour ago
DC Tharparkar inaugurates anti-polio campaign
1 hour ago
HDA Mehran workers demand salaries
1 hour ago
Taxila police nab motorcycle lifter gang
1 hour ago
Inter-university weightlifting championship kicks off at SAU
1 hour ago
Walk held in a series of enrollment campaigns
1 hour ago
Team from Gaza mediator Egypt arrives in Israel for truce talks
1 hour ago
Kids murders: IHC orders psychiatric examination of mother
1 hour ago
Health minister credits PML-N for advancements in organ transplantation
1 hour ago
Court grants interim bail to Azam Swati in cyber crime case
1 hour ago